• Chian-Shiu Chien, Chien-Ying Wang, Hsin-Bang Leu, Yueh Chien, Yi-Ping Yang, Chia-Lin Wang, Hsiao-Yun Tai, Yu-Ling Ko, Fu-Ting Tsai, Shih-Jie Chou, Wen-Chung Yu, and Meng-Yin Yang.
• Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
• J Chin Med Assoc. 2020 Jul 1; 83 (7): 657-660.

BackgroundHeart diseases, especially myocardial ischemia, remain one of the leading causes of mortality worldwide and usually result in irreparable cardiomyocyte damage and severe heart failure. Recent advances in induced pluripotent stem cell (iPSC) technologies for applied regenerative medicine and stem cell research, especially for iPSC-derived cardiomyocytes have increased the hope for heart repair. However, the driver molecules of myocardial differentiation and the functional reconstruction capacity of iPSC-derived cardiomyocytes are still questionable.MethodsHerein, we established a rapid differentiated platform that is involved in cardiomyogenic differentiation and maturation from iPSCs in vitro. Functional analysis is performed in miR-181a-transfected iPSC-derived cardiomyocyte (iPSC-cardio/miR-181a) under a time-lapse microscope. In addition, we calculated the beating area and frequency of iPSC-cardio/miR-181a cells in the presence of HCN4 shRNA or miR-181a SPONGE.ResultsmiR-181a enhanced the beating area and maintained the beating frequency of iPSC-derived cardiomyocytes by enhancing HCN4 expression.ConclusionmiR-181a would play a key role on maintaining proper beating function in iPSC-derived cardiomyocytes.

13 keywords...

hide…